SCHLAP1 and prostate carcinoma: SCHLAP1 is a biomarker to predict metastasis development and to discriminate high-risk from low-risk prostate cancer [384] and its dysregulation was found to be associated with aggressive intraductal and cribiform pathology of prostate cancer [386].